Webinar: Moving Stem Cell based Therapies to the Clinic
4 videos • 90 views • by California Institute for Regenerative Medicine The focus of this webinar is on the Lessons Learned from IND/Phase I trials including overcoming the challenges, and addressing the regulatory issues, as stem cell based therapies move towards the clinic. Presented April 15, 2013 Moderator: Ellen Feigal, M.D., Senior Vice President of Research and Development, CIRM Speakers: John Hyde, M.D., Ph.D, Medical Officer, Division of Clinical Evaluation and Pharmacology/Toxicology (DCEPT), Office of Cellular, Tissue and Gene Therapies (OCTGT), Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA) Eduardo Marbán, M.D., Ph.D., Founder and Chairman of Scientific Advisory Board, Capricor, Inc. and Director, Cedars-Sinai Heart Institute, Mark S. Siegel Family Professor Jonathan D. Glass, M.D., Professor, Neurology and Pathology, Emory University School of Medicine